Frequently asked questions on shorter MDR-TB regimen

The World Health Organization (WHO)'s Global TB Program has released Frequently asked questions about the implementation of the new WHO recommendation on the use of the shorter MDR-TB regimen under programmatic conditions.

These Frequently asked questions are to be read alongside the WHO treatment guidelines for drug-resistant tuberculosis, 2016 update released by the World Health Organization's Global TB Program in May 2016.

The Frequently asked questions can be accessed here.

To subscribe to the Weekly Newsletter of new posts, enter your email here:

By World Health Organization

Published: June 15, 2016, 3:27 p.m.

Last updated: June 15, 2016, 3:32 p.m.

Print Share